Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy

Heart

Volumn 76, Issue 5, 1996, Pages 412-417

  Sepp, Robert ^a,b   Severs, Nicholas J ^c   Gourdie, Robert G ^b,d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Connexin43; Desmosomes; Gap junctions; Hypertrophic cardiomyopathy

Indexed keywords

CONNEXIN 43;

ADULT; AGED; ARTICLE; CELL JUNCTION; DESMOSOME; FEMALE; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029801693     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.5.412     Document Type: Article

References (40)

1. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9, 844-52.
2. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44: 672-3.
3. Spirito P, Bellone P. Natural history of hypertrophic cardiomyopathy. Br Heart J 1994;72(suppl);S10-12.
4. Spiritio P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-55.
5. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989;80:1489-92.
6. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992;85(suppl I):I-57-63.
7. Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg H-P, Seidman JG, et al. A molecular basis for familial hypertrophic cardiomyopathy: an alfa/beta cardiac myosin heavy chain hybrid gene. Cell 1990;62:991-8.
8. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg H-P, McKenna WJ, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
9. Thierfelder L, Watkins H, McRae C, Lamas R, McKenna WJ, Vosberg H-P, et al. Alfa tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77:701-12.
10. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genetics 1995;11: 434-7.
11. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genetics 1995;11: 438-40.
12. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979;59:689-706.
13. St John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 1980;44:433-43.
14. Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 1981;63:882-94.
15. van der Bel-Kahn J. Muscle fibre disarray in common heart diseases. Am J Cardiol 1977;40:355-64.
16. Maron BJ, Sato N, Roberts WC, Edwards JE, Chandra RS. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation 1979;60:685-96.
17. Page E. Cardiac gap junctions. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system. New York: Raven Press, 1992: 1003-48.
18. Severs NJ. The cardiac gap junction and intercalated disc. Int J Cardiol 1990;26:137-73.
19. Green KJ, Geiger B, Jones JC, Tailan JC, Goldman RD. The relationship between intermediate filaments and microfilaments before and during the formation of desmosomes and adherens-type junctions in mouse epidermal keratinocytes. J Cell Biol 1987;104:1389-402.
20. Saffitz JE, Corr PB, Sobel BE. Arrhythmogenesis and ventricular dysfunction after myocardial infarction. Is anomalous cellular coupling the elusive link? Circulation 1993;87:1742-5.
21. Severs NJ. Pathophysiology of gap junctions in heart disease. J Cardiovasc Electrophysiol 1994;5:462-75.
22. Ursell PC, Gardner PI, Albala A, Fenoglio JJ, Wit AL. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res 1985;56:436-51.
23. Dillon SM, Allessie MA, Ursell PC, Wit AL. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 1988;63:182-206.
24. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ. Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 1991;139:801-21.
25. Saffitz JE, Hoyt RH, Luke RA, Kanter HL, Beyer EC. Cardiac myocyte interconnections at gap junctions - role in normal and abnormal electrical conduction. Trends Cardiovasc Med 1992;2:56-60.
26. Spach MS, Heidlage JF. A multidimensional model of cellular effects on the spread of electronic currents and on propagating action potentials. In: Pilkington TC, Lofts B, Thompson JF, Woo SL-Y, Palmer TC, Budinger TF, eds. High-performance computing in biomedical research. Boca Raton: CRC Press, 1993:289-317.
27. Arnemann J, Sullivan KH, Magee AI, King IA, Buxton RS. Stratification related expression of isoforms of the desmosomal cadherins in human epidermis. J Cell Sci 1993;104:741-50.
28. Gourdie RG, Severs NJ, Green CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of the cardiac atrioventricular conduction system. J Cell Sci 1993;105: 985-91.
29. Gourdie RG. A map of the heart: gap junctions, connexin diversity, and retroviral studies of conduction myocyte lineage. Clin Sci 1995;88:257-62.
30. Severs NJ, Gourdie RG, Harfst E, Peters NS, Green CR. Intercellular junctions and the application of microscopical techniques: the cardiac gap junction as a case model. J Microsc 1993;169:299-328.
31. Bonow RO. Left ventricular diastolic function in hypertrophic cardiomyopathy. Herz 1991; 16:13-21.
32. Lane NJ, Swales LS. Dispersal of junctional particles, not internalization, during the in vivo disappearance of gap junctions. Cell 1980;19:579-86.
33. Severs NJ, Shovel KS, Slade AM, Powell T, Twist VW, Green CR. Fate of gap junctions in isolated adult mammalian cardiomyocytes. Circ Res 1989;65:22-42.
34. Luque EA, Veenstra RD, Beyer EC, Lemanski LF. Localization and distribution of gap junctions in normal and cardiomyopathic hamster heart. J Morphol 1994;222: 203-13.
35. Gourdie RG, Green CR, Severs NJ, Thompson RP. Immunolabelling patterns of gap junction connexins in the developing and mature rat heart. Anat Embryol 1992; 185:363-78.
36. Oosthoek PW, Van Kempen MJA, Wessels A, Lamers WH, Moorman AFM. Distribution of the cardiac gap junction protein connexin43 in the neonatal and adult human heart. In: Muscle and motiliiy, vol 2. Proceedings of the XIXth European Conference in Brussels. 1993: 85-90.
37. Peters NS, Severs NJ, Rothery SM, Lincoln C, Yacoub MH, Green CR. Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 1994;90:713-25.
38. Maron BJ, Edwards JE, Henry WL, Clark CE, Bingle GJ, Epstein SE. Asymmetric septal hypertrophy (ASH) in infancy. Circulation 1974;50:809-20.
39. Maron BJ, Tajik AJ, Ruttenberg HD, Graham TP, Atwood GF, Victorica BE, et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982;65:7-17.
40. Maron BJ, Spiritio P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315:610-4.